<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>.01 Definitions. | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.09/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.09/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|09|03|.01|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="doc-num" content=".01"/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|09|03|.01" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.09.03.01"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content=".01 Definitions. | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.09/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.09/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message">Â </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09" data-search-heading="">
                  <a href="/us/md/exec/comar/10.09" title="Subtitle 09 MEDICAL CARE PROGRAMS">Subtitle 09 MEDICAL CARE PROGRAMS</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09|03" data-search-heading="">
                  <a href="/us/md/exec/comar/10.09.03" title="Chapter 03 Pharmacy Services">Chapter 03 Pharmacy Services</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09|03|.01" data-search-heading="">
                  <span title=".01 Definitions.">.01 Definitions.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|09|03|.01">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.09.03.01">.01 Definitions.</h1>
                <p class="text-indent-1 "><span class="level-num" id="A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(1)">(1)</span> "340B price" means the price at which drugs are purchased as authorized under Section 340B of the Public Health Service Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(2)">(2)</span> "Actual acquisition cost (AAC)" means the amount paid by a provider for a drug or product less all discounts, rebates, refunds, chargebacks, incentives, and price reductions.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(3)">(3)</span> "Allowable cost" means the maximum amount which the Program will reimburse for the drug or product portion of the prescription.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(4)">(4)</span> "Approved unit dose system" means a drug distribution system approved by the Department that is used to prepare and distribute an individual, properly labeled dose of medication for a patient in a nursing facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(5)">(5)</span> "Brand name drug" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(5)(a)">(a)</span> A single source drug;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(5)(b)">(b)</span> An innovator multiple source drug; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(5)(c)">(c)</span> A drug submitted for payment as brand medically necessary.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(6)">(6)</span> "Compounded prescription for intravenous therapy" means a prescription that:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(6)(a)">(a)</span> Combines two or more ingredients;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(6)(b)">(b)</span> Is prepared by using aseptic technique under a laminar flow clean bench; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(6)(c)">(c)</span> Is administered to a patient intravenously.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(7)">(7)</span> "Controlled substance" means a drug as defined under 21 U.S.C. Â§802.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(8)">(8)</span> "Convenience package" means a smaller or specially packaged quantity of a product prepared for the convenience of a patient or provider as opposed to the regular packaging.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(9)">(9)</span> "Copayment" means the amount a participant is liable to pay for prescriptions, when applicable, which is deducted from provider reimbursement.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(10)">(10)</span> "Department" means the Maryland Department of Health, the single State agency designated to administer the Medical Assistance Program under Title XIX, Social Security Act, 42 U.S.C. Â§1396 et seq.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(11)">(11)</span> "Diluent component" means a liquid used for reconstitution or dilution of an active ingredient in compounded prescription intravenous therapy.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(12)">(12)</span> "Direct price" means, for drugs identified by the Program, the price charged by a pharmaceutical manufacturer to a dispensing pharmacy for a product supplied to the pharmacy without intermediate distribution charges, less any rebates, discounts, refunds, chargebacks, incentives, and price reductions.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(13)">(13)</span> "Drugs" means legend drugs (those requiring a prescription under federal or State law) or over-the-counter (OTC) drugs (those not requiring a prescription under federal or State law).</p>
                <p class="text-indent-2 "><span class="level-num" id="B(14)">(14)</span> "Early and periodic screening, diagnosis, and treatment (EPSDT)" means a program of preventive health care services for Medical Assistance individuals younger than 21 years old.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(15)">(15)</span> "EPSDT-related service" means diagnosis and treatment necessary to correct or manage health problems detected by a screening performed by a certified EPSDT provider. EPSDT-related services are rendered by a certified EPSDT provider or an appropriate Medical Assistance provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(16)">(16)</span> "Family planning services" means providing individuals with the information and means to prevent unwanted pregnancy and maintain reproductive health.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(17)">(17)</span> "Federally qualified health center (FQHC)" means an entity as defined by Health-General Article, Â§24-1301, Annotated Code of Maryland, and Â§1905(l)(2)(B) of the Social Security Act.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(18)">(18)</span> "Federal supply schedule (FSS)" means the drug pricing program under the collection of multiple award contracts used by federal agencies, U.S. territories, Indian tribes, and other specified entities to purchase supplies and services from outside vendors.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(19)">(19)</span> "Federal upper limit (FUL)" means the upper limit of payment for multiple source drugs for which a specific maximum allowable cost has been established by the Centers for Medicare &amp; Medicaid Services (CMS) of the Department of Health and Human Services pursuant to 42 CFR Â§447.514.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(20)">(20)</span> "Freestanding clinics" means those clinics, not associated with a hospital, which are under the direction of physicians as further defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.08.01" title=".01 Definitions.">COMAR 10.09.08.01</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(21)">(21)</span> "Generic drug" means a drug that is:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(21)(a)">(a)</span> Available to pharmacy providers from at least one manufacturer;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(21)(b)">(b)</span> Rated as therapeutically equivalent by the U.S. Food and Drug Administration; and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(21)(c)">(c)</span> Not a brand name drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(22)">(22)</span> "Innovator multiple source drug" means a multiple source drug that was originally marketed under an original new drug application approved by the U.S. Food and Drug Administration.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(23)">(23)</span> "Institutional pharmacy" means a pharmacy owned and operated by a hospital, nursing facility, or clinic.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(24)">(24)</span> "Invoice" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(24)(a)">(a)</span> A form issued or approved by the Department for use by providers in submitting bills for payment; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(24)(b)">(b)</span> A bill issued by a manufacturer or wholesaler to a provider which indicates proof of purchase and the:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(24)(b)(i)">(i)</span> Actual acquisition cost paid by the provider; or</p>
                <p class="text-indent-4 "><span class="level-num" id="B(24)(b)(ii)">(ii)</span> The direct price charged to the provider by the manufacturer.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(25)">(25)</span> "Maintenance medication" means medication in chronic therapeutic categories corresponding to the following American Hospital Formulary Service (AHFS) classification numbers:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(a)">(a)</span> Cardiac drugs (24:04);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(b)">(b)</span> Antilipemic agents (24:06);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(c)">(c)</span> Hypotensive agents (24:08);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(d)">(d)</span> Vasodilating agents (24:12);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(e)">(e)</span> Sclerosing agents (24:16);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(f)">(f)</span> Alpha-adrenergic blocking agents (24:20);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(g)">(g)</span> Beta-adrenergic blocking agents (24:24);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(h)">(h)</span> Calcium-channel blocking agents (24:28);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(i)">(i)</span> Renin-angiotensin-aldosterone system inhibitors (24:32);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(j)">(j)</span> Hydantoins (28:12:12);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(k)">(k)</span> Oxazolidinediones (28:12:16);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(l)">(l)</span> Succinimides (28:12:20);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(m)">(m)</span> Anticonvulsants, miscellaneous (28:12:92);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(n)">(n)</span> Replacement solutions (40:12) (potassium supplements only);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(o)">(o)</span> Diuretics (40:28);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(p)">(p)</span> Lipotropic agents (56:24);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(q)">(q)</span> Contraceptives (68:12);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(r)">(r)</span> Estrogens and antiestrogens (68:16);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(s)">(s)</span> Antidiabetic agents (68:20);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(t)">(t)</span> Antihypoglycemic agents (68:22);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(u)">(u)</span> Parathyroid (68:24);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(v)">(v)</span> Progestins (68:32);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(w)">(w)</span> Thyroid and antithyroid agents (68:36);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(x)">(x)</span> Vitamins (88:00);</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(y)">(y)</span> Sodium fluoride (92:00); and</p>
                <p class="text-indent-3 "><span class="level-num" id="B(25)(z)">(z)</span> Iron preparations, oral (20.04.04) (oral products in which ferrous sulfate is the only active ingredient and chewable tablets of any ferrous salt if combined with vitamin C, multivitamins, multivitamins and minerals, or other minerals in the formulation).</p>
                <p class="text-indent-2 "><span class="level-num" id="B(26)">(26)</span> "Medical Assistance Program" means a program of comprehensive medical and other health-related care for indigent and medically indigent persons.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(27)">(27)</span> "National average drug acquisition cost (NADAC)" means the average price paid by retail community pharmacies to acquire a prescription or over-the-counter covered out-patient drug as calculated by the Centers for Medicare and Medicaid Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(28)">(28)</span> "Nominal price" means a price that is less than 10 percent of the average manufacturer price (AMP) in the same quarter for which AMP is computed.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(29)">(29)</span> "Nursing facility" means an institution as further defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.09.10.01#B(30)" title="">COMAR 10.09.10.01B(30)</a>, and classified as a long-term care facility.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(30)">(30)</span> "Participant" means a person who is certified as eligible for and is receiving Medical Assistance benefits.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(31)">(31)</span> "Pharmacist" means an individual licensed in good standing to practice pharmacy in the state where the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(32)">(32)</span> "Pharmacy" means an establishment or institution licensed in good standing that is required to obtain a permit in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, or a similar entity legally authorized to dispense legend drugs to the public in the state in which the establishment or institution is located.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(33)">(33)</span> "Pharmacy and Therapeutics Committee" means a committee established by the Department to develop recommendations for pharmacy practices including but not limited to development of a preferred drug list according to <a class="internal-link " href="/us/md/exec/comar/10.09.03.12" title=".12 Preferred Drug Program.">Regulation .12 of this chapter</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(34)">(34)</span> "Preauthorization" means an approval required from the Department or its designee before a drug is dispensed.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(35)">(35)</span> "Preferred drug list" means a list of recommended drugs developed by the Department that is based on the recommendations of the Pharmacy and Therapeutics Committee.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(36)">(36)</span> "Prescriber" means a physician, dentist, podiatrist, or other professional licensed in good standing to prescribe legend drugs in the state in which the service is provided.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(37)">(37)</span> "Prescription" means an order by a prescriber, or a prescriberâs order transferred from one pharmacist to another, for Program covered pharmacy services in accordance with applicable federal and State laws conveyed in one of the following forms:</p>
                <p class="text-indent-3 "><span class="level-num" id="B(37)(a)">(a)</span> An original order signed by the prescriber and written on tamper-resistant paper which shall contain industry-recognized features designed to prevent:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(37)(a)(i)">(i)</span> Unauthorized copying of a prescription form;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(37)(a)(ii)">(ii)</span> Erasure or modification of information written on the prescription by the prescriber; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(37)(a)(iii)">(iii)</span> Use of counterfeit prescription forms;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(37)(b)">(b)</span> A fax of an original order signed by the prescriber sent directly from the prescriber to the pharmacy provider;</p>
                <p class="text-indent-3 "><span class="level-num" id="B(37)(c)">(c)</span> An electronic order; or</p>
                <p class="text-indent-3 "><span class="level-num" id="B(37)(d)">(d)</span> An oral order from the prescriber to the pharmacist if the:</p>
                <p class="text-indent-4 "><span class="level-num" id="B(37)(d)(i)">(i)</span> Pharmacist promptly writes or prints out and files the prescription;</p>
                <p class="text-indent-4 "><span class="level-num" id="B(37)(d)(ii)">(ii)</span> Prescription is not for a Schedule II controlled dangerous substance; and</p>
                <p class="text-indent-4 "><span class="level-num" id="B(37)(d)(iii)">(iii)</span> Prescription is not for certain drugs that have been determined by the Secretary to present an emerging threat in the State because of increasing abuse and diversion.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(38)">(38)</span> "Professional dispensing fee" means the professional fee as defined in 42 CFR Â§447.502.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(39)">(39)</span> "Program" means the Maryland Medical Assistance Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(40)">(40)</span> "Provider" means an individual, association, partnership, or incorporated or unincorporated group of individuals duly licensed or certified to provide services for recipients and who, through appropriate agreement with the Department, has been identified as a Program provider by issuance of an individual account number.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(41)">(41)</span> "Single source drug" means a covered drug which is produced or distributed under an original new drug application approved by the Food and Drug Administration, including a drug product marketed by any cross-licensed producers or distributors operating under the new drug application.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(42)">(42)</span> "State actual acquisition cost (SAAC)" means, for those drugs or products identified by the Program, the Programâs or its designeeâs calculation of AAC, based on a survey of providersâ actual prices paid to acquire drugs or products marketed or sold by specific manufacturers, when NADAC is unavailable.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(43)">(43)</span> "State Formulary" means drug products listed in the United States Food and Drug Administration's Current List of Approved Drug Products with Therapeutic Equivalence Evaluations unless disqualified by the Department in conformity with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-504" title="">Health Occupations Article, Â§12-504, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(44)">(44)</span> "State-only participants" means those participants in the Program administered and financed by the State who do not meet the technical requirements of Title XIX of the Social Security Act and for whom the State does not claim federal financial participation.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(45)">(45)</span> "Usual source of supply" means a wholesaler, distributor, or manufacturer from whom pharmacy providers within the State most frequently obtain their pharmaceuticals.</p>
                <p class="text-indent-2 "><span class="level-num" id="B(46)">(46)</span> "Wholesale acquisition cost (WAC)" means the price pharmaceutical manufacturers and distributors charge to wholesale distributors who provide retail and institutional pharmacies with products used to fill prescriptions.</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.09.03" aria-label="Chapter 03 Pharmacy Services">
                <div class="h__ui">Previous</div>
                <span>Chapter 03 Pharmacy Services</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.09.03.02" aria-label=".02 License Requirements.">
                <div class="h__ui">Next</div>
                <span>.02 License Requirements.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">

<p>
      Please do not scrape. Instead, bulk download the CC-BY-NC-SA-4.0 <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
